Page last updated: 2024-08-21

alpha-aminopyridine and Primary Myelofibrosis

alpha-aminopyridine has been researched along with Primary Myelofibrosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bharathy, S; Chuah, C; Dong, T; Durrant, ST; Gisslinger, H; Guglielmelli, P; Lavie, D; le Coutre, P; Lopez, JM; Maffioli, M; Nagler, A; Wroclawska, M	1

Trials

1 trial(s) available for alpha-aminopyridine and Primary Myelofibrosis

Article	Year
Results from HARMONY: an open-label, multicenter, 2-arm, phase 1b, dose-finding study assessing the safety and efficacy of the oral combination of ruxolitinib and buparlisib in patients with myelofibrosis. Haematologica, 2019, Volume: 104, Issue:12 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Female; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Middle Aged; Morpholines; Nitriles; Primary Myelofibrosis; Prognosis; Pyrazoles; Pyrimidines; Tissue Distribution	2019

Article

Year

Results from HARMONY: an open-label, multicenter, 2-arm, phase 1b, dose-finding study assessing the safety and efficacy of the oral combination of ruxolitinib and buparlisib in patients with myelofibrosis.

Haematologica, 2019, Volume: 104, Issue:12

Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Female; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Middle Aged; Morpholines; Nitriles; Primary Myelofibrosis; Prognosis; Pyrazoles; Pyrimidines; Tissue Distribution

2019